Ce este Co-Codamol (Paracetamol/Codeine)?
Co-Codamol is a combination prescription analgesic containing two active ingredients: paracetamol and codeine phosphate. It provides stronger pain relief than paracetamol alone and is indicated for the short-term treatment of moderate pain in adults and adolescents aged 12 and over. Higher-strength formulations (30/500 mg) are prescription-only medicines across the European Union.
Cum funcționează Co-Codamol (Paracetamol/Codeine)?
Co-Codamol achieves its analgesic effect through two complementary mechanisms:
- Paracetamol component: Paracetamol (also known as acetaminophen) works centrally in the brain to inhibit the synthesis of prostaglandins involved in pain signalling and temperature regulation. It does not significantly reduce inflammation at peripheral sites of injury.
- Codeine component: Codeine is a prodrug that is metabolised in the liver to morphine, a potent opioid analgesic. Morphine binds to mu-opioid receptors in the central and peripheral nervous system, inhibiting the transmission of pain signals and altering the perception of pain. Codeine also has antitussive (cough-suppressing) and antidiarrhoeal properties.
- Synergistic effect: The combination of a centrally acting analgesic (paracetamol) and an opioid (codeine) produces additive or synergistic pain relief at lower individual doses of each component than would be required if used separately.
The extent of codeine’s analgesic effect depends on individual genetic variation in the CYP2D6 enzyme. Poor metabolisers derive little benefit; ultra-rapid metabolisers may experience exaggerated opioid effects at standard doses.
Pentru cine este indicat Co-Codamol (Paracetamol/Codeine)?
Co-Codamol is indicated for adults and adolescents (12 years and over) experiencing moderate pain that is not adequately controlled by non-opioid analgesics alone. Typical indications include:
- Musculoskeletal pain: Back pain, joint pain, and soft tissue injuries
- Dental pain: Toothache, post-extraction discomfort
- Headache and migraine: When standard analgesics have been insufficient
- Post-operative pain: Short-term management following minor surgical procedures
- Dysmenorrhoea: Moderate menstrual pain
Co-Codamol is not appropriate for children under 12 years, patients under 18 following certain surgical procedures (such as tonsillectomy), patients who are known ultra-rapid CYP2D6 metabolisers, or those with significant respiratory depression or severe hepatic impairment. It must not be used during breastfeeding. A full medical assessment is required before prescribing.
Dozaj
Co-Codamol is available in several strengths, the most common being 8/500 mg and 30/500 mg (codeine/paracetamol). Prescription-strength formulations (30/500 mg) are the subject of this page.
| Patient Group | Dose | Maximum Daily Dose |
|---|---|---|
| Adults (18+) | 30/500 mg, 1–2 tablets every 4–6 hours | 8 tablets (240 mg codeine / 4,000 mg paracetamol) per 24 hours |
| Adolescents (12–17) | 30/500 mg, 1 tablet every 6 hours | 4 tablets (120 mg codeine / 2,000 mg paracetamol) per 24 hours |
Important: Co-Codamol is intended for short-term use only (maximum 3 days). If pain persists beyond three days, patients should seek medical review rather than continuing treatment independently. The maximum paracetamol dose across all products must not exceed 4,000 mg per day; patients must not take Co-Codamol alongside other paracetamol-containing products.
Efecte secundare
As with all medicines, Co-Codamol may cause side effects. The codeine component in particular carries important risks that patients should be aware of.
Common side effects (may affect up to 1 in 10 people)
- Constipation (the most common opioid side effect)
- Nausea and vomiting
- Dizziness and lightheadedness
- Drowsiness
- Headache
- Dry mouth
Efecte secundare mai puțin frecvente, dar grave
- Dependence and withdrawal: Codeine is an opioid and can cause physical and psychological dependence even at therapeutic doses with prolonged use. Abrupt discontinuation after extended use may cause withdrawal symptoms.
- Respiratory depression: Codeine can suppress the respiratory drive, particularly at higher doses or in ultra-rapid metabolisers. This is a medical emergency.
- Hepatotoxicity: Paracetamol overdose — even inadvertent overdose from taking multiple paracetamol-containing products simultaneously — is a leading cause of acute liver failure. Never exceed the maximum paracetamol daily dose.
- Serotonin syndrome: Risk exists when codeine is used with other serotonergic drugs (SSRIs, MAOIs, triptans).
- Allergic reactions: Rare hypersensitivity reactions including skin rashes and anaphylaxis have been reported.
This is not a complete list of side effects. Refer to the EMA-approved product information for full prescribing details.
Cum puteți obține Co-Codamol (Paracetamol/Codeine) online în Europa
Higher-strength Co-Codamol (30/500 mg) is a prescription-only medicine (POM) throughout the European Union. It cannot be legally dispensed without a valid prescription from a licensed medical professional.
Prescrivia operates as a technology intermediary platform: we do not prescribe medicines, employ doctors, or sell medicines. Our platform connects patients with independent EU-registered doctors who can conduct confidential online health assessments.
Procesul este următorul:
- Completați un chestionar medical: Answer a structured set of health questions covering your medical history, pain history, current medications, and any prior use of opioid-containing medicines.
- Evaluarea medicului: An independent EU-registered doctor reviews your assessment. If Co-Codamol is clinically appropriate for your situation, they may issue a short-term prescription. If it is not appropriate, the doctor will advise on alternatives.
- Prescripție și livrare: If a prescription is issued, it is forwarded to a licensed EU pharmacy partner, which dispenses and ships the medicine directly to you.
Important: Prescrivia nu garantează că o prescripție va fi emisă. Toate deciziile de prescriere sunt luate independent de medici calificați, pe baza circumstanțelor dumneavoastră clinice individuale.
Informații importante privind siguranța
Nu utilizați Co-Codamol (Paracetamol/Codeine) dacă:
- Are under 12 years of age
- Are under 18 and have had your tonsils or adenoids removed for sleep apnoea
- Are breastfeeding (codeine passes into breast milk and can cause serious harm to the infant)
- Are a known ultra-rapid CYP2D6 metaboliser
- Have severe respiratory disease, severe asthma, or conditions causing respiratory depression
- Are taking or have recently taken MAO inhibitors (within 14 days)
Informați medicul dumneavoastră înainte de a începe Co-Codamol (Paracetamol/Codeine) dacă aveți:
- Liver or kidney disease
- A history of opioid dependence or substance misuse
- Inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
- Hypothyroidism or Addison’s disease
- A head injury or raised intracranial pressure
- A history of asthma or breathing disorders
Interacțiuni medicamentoase: Co-Codamol interacts with alcohol (increased CNS depression), sedatives, benzodiazepines, antidepressants, antiepileptics, and other opioids. Alcohol must be avoided during treatment. Always disclose all current medications to your doctor during the assessment.
Co-Codamol is not appropriate for long-term pain management. Persistent or recurring pain should be assessed and managed with a comprehensive care plan by a qualified doctor.
Surse
Informațiile medicale de pe această pagină se bazează pe următoarele surse:
- European Medicines Agency (EMA). Assessment report for codeine-containing products — Paediatric use restrictions. EMA/PRAC/221275/2013.
- World Health Organization (WHO). WHO Model List of Essential Medicines — Analgesics. who.int
- Derry S, et al. Single dose oral codeine, as a single agent, for acute postoperative pain in adults. Cochrane Database Syst Rev. 2010.
- European Medicines Agency (EMA). Questions and answers on the use of codeine for pain relief in children. Available at: ema.europa.eu
Acest conținut este revizuit periodic pentru a reflecta ghidurile clinice actualizate. Este furnizat exclusiv în scop informativ și nu constituie sfat medical. Consultați întotdeauna un profesionist medical calificat pentru sfaturi relevante pentru circumstanțele dumneavoastră individuale de sănătate.
Frequently asked questions
- Pentru ce se utilizează Co-Codamol (Paracetamol/Codeine)?
- Co-Codamol is a combination analgesic containing paracetamol and codeine phosphate. It is used for the short-term treatment of moderate pain that has not responded adequately to paracetamol or ibuprofen alone, including headaches, dental pain, musculoskeletal pain, and post-operative pain.
- Is Co-Codamol stronger than paracetamol alone?
- Yes. The addition of codeine — a mild opioid analgesic — to paracetamol provides enhanced pain relief for moderate pain that does not respond sufficiently to paracetamol on its own. Clinical evidence supports the combination being more effective for moderate pain than either ingredient alone at standard doses.
- Pot obține Co-Codamol (Paracetamol/Codeine) online în Europa?
- Puteți accesa acest medicament prin platforme intermediare online care vă conectează cu medici independenți înregistrați în UE. După completarea unui chestionar medical confidențial, un medic va evalua dacă medicamentul este adecvat clinic pentru dumneavoastră.
- Care sunt cele mai frecvente efecte secundare?
- Common side effects include constipation, nausea, dizziness, drowsiness, and headache. The codeine component carries a risk of dependence with prolonged use, which is why it should only be used for short durations and under medical supervision.
- Can Co-Codamol be habit forming?
- Yes. Codeine is an opioid and carries a risk of psychological and physical dependence, particularly with prolonged use or higher doses. Co-Codamol is intended for short-term use only, and patients should not use it for longer than three days without medical guidance.
Tratamente
Prescrivia este doar o platformă intermediară. Nu furnizăm servicii medicale, nu prescriem tratamente și nu eliberăm medicamente. Toate deciziile medicale sunt luate de medici independenți înregistrați în UE. Toate medicamentele sunt eliberate de farmacii licențiate din UE. Această platformă facilitează legătura între pacienți și furnizorii de servicii medicale.